English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 1/5 criteria met.
- ❌ Price trend failed
- ❌ Growth failed
- ✅ Debt passed
- ❌ P/E failed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2020 → 2021: -22.46%
Price change 2021 → 2022: -76.75%
Price change 2022 → 2023: 9.84%
Price change 2023 → 2024: 34.33%
Price change 2024 → 2025: -59.26%
Price change 2025 → 2026: -35.24%
Price change 2026 (year to date): -38.59%
Financial growth
Revenue CAGR (7 years): N/A
Earnings CAGR (7 years): N/A
Growth status: insufficient data or negative trend.
Debt
Debt-to-equity ratio: 0.02
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: -3.37
P/E > 25.0 (maximum threshold).
Correction (6 months)
Current correction: 44.34% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="QSI" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Quantum-Si incorporated | – | 0.02 | – | 🔒 |
| Eurobio Scientific S.A. | 36.8 | 0.09 | +22.1 % | – |
| Prenetics Global Limited | – | 0.01 | +46.8 % | – |
| LNA Santé S.A. | 9.7 | 2.75 | +10.4 % | – |
| Valerio Therapeutics S.A. | – | 3.67 | −13.5 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Quantum-Si incorporated over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2023 | 1.1 m | -96.0 m | -8,868.8 % | n/a |
| 2024 | 3.1 m | -101 m | -3,303.0 % | +182.6 % |
| 2025 | 2.4 m | -101 m | -4,160.1 % | -20.3 % |
Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Quantum-Si incorporated over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 471 m | 351 m | 258 m | 210 m | 163 m |
| Total Debt | 8.1 m | 17.4 m | 15.3 m | 12.9 m | 4.2 m |
| Net Debt | -27.7 m | -66.9 m | -119 m | -36.3 m | -17.5 m |
| Equity | 477 m | 359 m | 272 m | 215 m | 220 m |
| Total assets | 503 m | 391 m | 298 m | 248 m | 246 m |
| Operating cash flow | -66.8 m | -90.6 m | -94.0 m | -87.8 m | -94.7 m |
| Investments (capex) | 5.8 m | 10.7 m | 4.5 m | 4.6 m | 2.5 m |
| Free cash-flow | -72.6 m | -101 m | -99.3 m | -92.4 m | -97.2 m |
| Share buybacks | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.
Analyst consensus and forecasts
What the financial analysts covering Quantum-Si incorporated publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Price targets: published for companies listed in the United States only.
Track record against expectations: reported EPS above consensus 8 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 07/11/2026. An analyst rating or target is not a guarantee.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Quantum-Si incorporated.
Large funds tracked
| Fund | Shares | Value (USD) | Weight in the fund | Change | Quarter |
|---|---|---|---|---|---|
| Vanguard Group | 9.6 m | 10.6 m | 0.0 % | +10.2 % | 2025Q4 |
| ARK Investment Management | 7.2 m | 6.3 m | 0.0 % | +4.2 % | 2026Q2 |
| BlackRock | 5.2 m | 4.6 m | 0.0 % | -61.0 % | 2026Q2 |
| Millennium Management | 3.1 m | 2.8 m | 0.0 % | n/a | 2026Q2 |
| AQR Capital Management | 2.3 m | 2.1 m | 0.0 % | -1.8 % | 2026Q2 |
| Geode Capital Management | 2.2 m | 2.0 m | 0.0 % | -41.7 % | 2026Q2 |
| State Street | 1.8 m | 1.6 m | 0.0 % | -52.8 % | 2026Q2 |
| Renaissance Technologies | 553,871 | 490,176 | 0.0 % | +369.8 % | 2026Q2 |
Latest insider transactions
| Date | Person | Side | Amount |
|---|---|---|---|
| 22/09/2026 | Hawkins Jeffrey Alan | sale | 7,387 USD |
| 22/09/2026 | Keyes Jeffry R. | sale | 1,897 USD |
| 22/09/2026 | Lapointe Christian | sale | 3,592 USD |
| 21/09/2026 | Hawkins Jeffrey Alan | sale | 15,224 USD |
| 21/09/2026 | Keyes Jeffry R. | sale | 3,909 USD |
| 21/09/2026 | Lapointe Christian | sale | 7,403 USD |
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 08/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Quantum-Si incorporated
What is the Quantum-Si incorporated share price?
Latest recorded price: 1.33 USD on 06/11/2026, for a market cap of 265 m USD.
What is the revenue of Quantum-Si incorporated?
2.4 m USD for fiscal year 2025, with net income of -101 m USD (net margin -4,160.1 %).
What do analysts say about Quantum-Si incorporated?
Out of 2 analysts: 1 buy or strong buy, 1 hold, 0 sell or strong sell.
Is Quantum-Si incorporated stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US74765K1051).
How many employees does Quantum-Si incorporated have?
149 full-time employees according to the latest published profile.
Who runs Quantum-Si incorporated?
Jeffrey Alan Hawkins is the company's chief executive.
Which large funds own Quantum-Si incorporated?
As of 2026Q2, among the large funds tracked: Vanguard Group, ARK Investment Management, BlackRock, Millennium Management, AQR Capital Management.